Key result
Intramyocardial injection of human endometrial stem cells improved ejection fraction by 15% and preserved viable myocardium in a rat model of myocardial infarction via paracrine mechanisms.
Why the study?
Does intramyocardial injection of human endometrial stem cells improve cardiac function and preserve viable myocardium in a rat model of myocardial infarction?
Does intramyocardial injection of human endometrial stem cells improve cardiac function and preserve viable myocardium in a rat model of myocardial infarction?
Effect estimate: 15% improvement
p-value: p=<0.05
Human endometrial stem cells improve cardiac function and preserve viable myocardium post-myocardial infarction in rats, primarily via paracrine mechanisms rather than direct differentiation.
No takes yet. Share an insight, caveat, or question.
Supports paracrine benefits of endometrial stem cells in rodent MI; leaves open translation to clinical practice.
Jiang et al. (2013) studied Myocardial infarction. Human endometrial stem cells (EnSCs) vs. PBS was evaluated on Ejection fraction (15% improvement, p=<0.05). Intramyocardial injection of human endometrial stem cells improved ejection fraction by 15% and preserved viable myocardium in a rat model of myocardial infarction via paracrine mechanisms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: